CRISPR/Cas9‐Mediated Knockouts of the ALG3 and GNTI in N. benthamiana and Their Application to Pharmaceutical Production
Plant Biotechnology Journal · 2025
DOI: 10.1111/pbi.70326 ↗Kurz gefasst
Fachartikel in der Zeitschrift Plant Biotechnology Journal, 2025. Verfasst von Dolgormaa Bataa und 7 weiteren Autor:innen. Beteiligte Einrichtung: International Center for Biotechnology, University of Osaka, Osaka, Japan. Hauptthemen laut MEDLINE: Nicotiana, CRISPR-Cas Systems, Plant Proteins. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
N ‐Glycosylation critically influences the efficacy, safety and pharmacokinetic properties of biopharmaceuticals. Plant expression platforms offer multiple advantages for the production of N ‐glycosylated proteins, but their use is impeded by the presence of plant‐specific N ‐glycan epitopes, which raise concerns of possible immunogenicity to humans. In this study, N ‐glycoengineered Nicotiana benthamiana plants that produce more homogeneous N ‐glycans without plant‐specific epitopes were generated using multiplex CRISPR/Cas9 genome editing. To achieve this N ‐glycosylation modification, ALG3 and GNTI, which function in N ‐glycosylation processes in the ER and Golgi, respectively, were characterised, and single‐ and double‐knockout mutant plants were generated. Comprehensive N ‐glycan profiling revealed that while the ALG3 ‐knockout plant line, alg3 , maintained predominantly plant‐specific N ‐glycans with altered mannose content, the GNTI ‐knockout line, gntI , produced exclusively high‐mannose‐type N ‐glycans. Notably, the alg3gntI double‐knockout mutants yielded highly uniform trimannosidic N ‐glycans. To validate our N ‐glycoengineering approach, we expressed two model biopharmaceuticals, Varlilumab (anti‐CD27 antibody) and β‐glucocerebrosidase (GCase), in wild‐type and mutant plants. While the antibodies expressed in alg3 and alg3gntI showed a certain level of glucosylated endoplasmic reticulum‐type N ‐glycan, with increased non‐ N ‐glycosylated heavy chains, GCase exhibited a more consistent N‐ glycosylation profile, reflecting the engineered N ‐glycosylation pathway. Our findings provide valuable insights into N ‐glycan biosynthesis in N. benthamiana and demonstrate the potential of targeted N ‐glycoengineering for producing biopharmaceuticals with more homogeneous mannose‐type N ‐glycan profiles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- International Center for Biotechnology, University of Osaka, Osaka, Japan.
- Department of Biotechnology, Graduate School of Engineering, University of Osaka, Osaka, Japan.
- Department of Medical Technology and Clinical Engineering, Gunma University of Health and Welfare, Maebashi, Japan.
- Institute for Open and Transdisciplinary Research Initiatives (OTRI), University of Osaka, Osaka, Japan.
- College of Life Sciences, Ritsumeikan University, Kusatsu, Japan.
- Osaka University Cooperative Research Station in Southeast Asia (OU:CRS), Faculty of Science, Mahidol University, Bangkok, Thailand.
ORCID-Profile: Kazuhito Fujiyama
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Bataa, D., Kajiura, H., Sawada-Choi, R. L. S., Yamashita, Y., Ishimizu, T., Misaki, R., Takeda, A., & Fujiyama, K. (2025). CRISPR/Cas9‐Mediated Knockouts of the ALG3 and GNTI in N. benthamiana and Their Application to Pharmaceutical Production. Plant Biotechnology Journal. https://doi.org/10.1111/pbi.70326
Vancouver
Bataa D, Kajiura H, Sawada-Choi RLS, Yamashita Y, Ishimizu T, Misaki R, et al. CRISPR/Cas9‐Mediated Knockouts of the ALG3 and GNTI in N. benthamiana and Their Application to Pharmaceutical Production. Plant Biotechnology Journal. 2025. doi:10.1111/pbi.70326
BibTeX
@article{Bataa2025,
author = {Bataa, Dolgormaa and Kajiura, Hiroyuki and Sawada-Choi, Reimi Lai Sang and Yamashita, Yukino and Ishimizu, Takeshi and Misaki, Ryo and Takeda, Atsushi and Fujiyama, Kazuhito},
title = {CRISPR/Cas9‐Mediated Knockouts of the ALG3 and GNTI in N. benthamiana and Their Application to Pharmaceutical Production},
journal = {Plant Biotechnology Journal},
year = {2025},
doi = {10.1111/pbi.70326}
}
EUVIMED